137 related articles for article (PubMed ID: 10839470)
1. Ethnic differences in response to non-selective beta-blockade among racial groups in Malaysia.
Rasool AH; Rahman AR; Ismail R; Hatim S; Abdullah AR; Singh R; Haron R
Int J Clin Pharmacol Ther; 2000 May; 38(5):260-9. PubMed ID: 10839470
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites.
Zhou HH; Koshakji RP; Silberstein DJ; Wilkinson GR; Wood AJ
N Engl J Med; 1989 Mar; 320(9):565-70. PubMed ID: 2536896
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels.
Hughes K; Yeo PP; Lun KC; Thai AC; Sothy SP; Wang KW; Cheah JS; Phoon WO; Lim P
J Epidemiol Community Health; 1990 Mar; 44(1):29-35. PubMed ID: 2348145
[TBL] [Abstract][Full Text] [Related]
5. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.
Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM
Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694
[TBL] [Abstract][Full Text] [Related]
6. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
Conviser JM; Ng AV; Rockey SS; Thomas DP
J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
Hughes K; Ong CN
J Epidemiol Community Health; 2000 Jan; 54(1):31-4. PubMed ID: 10692959
[TBL] [Abstract][Full Text] [Related]
8. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
Bauer K; Dietersdorfer F; Kaik G
Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
[TBL] [Abstract][Full Text] [Related]
9. Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade.
Fletcher GF; Sweeney ME; Fletcher BJ
Am Heart J; 1991 Jan; 121(1 Pt 1):105-10. PubMed ID: 1670740
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and pulmonary effects of acebutolol.
Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Ferro A; Hall JA; Dickerson JE; Brown MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
13. O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m.
Wolfel EE; Selland MA; Cymerman A; Brooks GA; Butterfield GE; Mazzeo RS; Grover RF; Reeves JT
J Appl Physiol (1985); 1998 Sep; 85(3):1092-102. PubMed ID: 9729588
[TBL] [Abstract][Full Text] [Related]
14. Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
McLeod AA; Knopes KD; Shand DG; Williams RS
Br J Clin Pharmacol; 1985 Jan; 19(1):13-20. PubMed ID: 2858214
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans.
McLeod AA; Brown JE; Kitchell BB; Sedor FA; Kuhn C; Shand DG; Williams RS
J Appl Physiol Respir Environ Exerc Physiol; 1984 Mar; 56(3):716-22. PubMed ID: 6142878
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
18. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D; MacDonald IA; Heller SR; Tattersall RB
Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
[TBL] [Abstract][Full Text] [Related]
20. [Effects of beta-adrenergic receptor blockade on hyperlactacidemia induced by exercise of different intensity].
Scheen A; Camus G; Fossion A
Arch Int Physiol Biochim Biophys; 1991 Aug; 99(4):331-4. PubMed ID: 1723323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
